An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II | MicrobiomeTrials← Back to trialsNCT05754450
An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2023-04-10Est. Completion: 2026-12-31
Enrollment target: 2 participants Locations- Mayo Clinic, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
LAD-1DOCK8GATA2 Deficancy
Background:
\- Gene therapy is being investigated as a possible treatment for individuals with immunodeficiency disease…
Bethesda, United States
Metabolic Syndrome
This randomized, double-blind, placebo-controlled, parallel-group study evaluated the effects of six-month oral suppleme…
Wroclaw, PolandCompleted Jun 25, 2026
Chronic Granulomatous Disease (CGD)
X-Linked Severe Combined Immune Deficiency (XSCID)
Leukocyte Adhesion Deficiency 1 (LAD)
Graft Versus Host Disease (cGvHD)
This study will evaluate patients with abnormal immune function that results in recurrent or unusual infections or chron…